Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 13.82% vs -15.19% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -38.64% vs 70.11% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is -219.15% vs 105.63% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is -1.19% vs -5.62% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
Compare Quarterly Results Of Fujian Cosunter Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 13.82% vs -15.19% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 13.47% vs 10.11% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -38.64% vs 70.11% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -91.12% vs 78.75% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -219.15% vs 105.63% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -366.67% vs 105.77% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -1.19% vs -5.62% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -4.60% vs 0.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






